Effects of diuretics on plasma lipoproteins in healthy men View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1980-07

AUTHORS

C. Joos, H. Kewitz, D. Reinhold-Kourniati

ABSTRACT

The fasting level of plasma very low density lipoproteins (VLDL) was increased by 30 to 50% in 12 healthy male volunteers treated with daily oral doses of hydrochlorothiazide 100 mg, chlorthalidone 100 mg or furosemide 80 mg for 3 weeks in a cross-over trial. Hydrochlorothiazide and chlorthalidone, but not furosemide, caused a 10% increase in cholesterol in the low density lipoproteins (LDL), whereas triglycerides and phospholipids in this fraction remained unchanged. High density lipoproteins (HDL) were not affected by any of the diuretics. Free palmitic and oleic acid in plasma were also increased during the treatment, perhaps because of an accumulation of cyclic 3′5′-AMP due either to the inhibitory action of diuretics on phosphodiesterase, or to secondary activation of the sympathetic nervous systems. This would activate lipolysis in fat tissue, which in turn may induce VLDL synthesis in the liver. Each of the diuretics caused a similar rise of 20 to 30% in the mean plasma uric acid, the which could not be correlated with either triglycerides or cholesterol. Plasma sodium was increased by 2% only by furosemide, whereas potassium was decreased by 15 and 19% by hydrochlorothiazide and chlorthalidone, respectively, but not by furosemide. Mean plasma creatinine rose by 3.5% on treatment with furosemide, and by 6% with the other two diuretics. Mean body weight was reduced by 1,4 to 2,0% during treatment. No change in fasting blood sugar, plasma protein level or hematocrit was found. More... »

PAGES

251-257

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00625798

DOI

http://dx.doi.org/10.1007/bf00625798

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1029985014

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6995127


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1101", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biochemistry and Metabolomics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chlorthalidone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuretics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fatty Acids, Nonesterified", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Furosemide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydrochlorothiazide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins, HDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins, LDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins, VLDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phospholipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Placebos", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium Chloride Symporter Inhibitors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Clinical Pharmacology, Free University of Berlin, Klinikum Steglitz, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joos", 
        "givenName": "C.", 
        "id": "sg:person.01370452303.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370452303.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Clinical Pharmacology, Free University of Berlin, Klinikum Steglitz, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kewitz", 
        "givenName": "H.", 
        "id": "sg:person.0577236243.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577236243.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Clinical Pharmacology, Free University of Berlin, Klinikum Steglitz, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reinhold-Kourniati", 
        "givenName": "D.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1177/000331977602701205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002523464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/000331977602701205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002523464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1964.03070220062023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006015100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.1960.tb20075.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006784252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00593171", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010779101", 
          "https://doi.org/10.1007/bf00593171"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00593171", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010779101", 
          "https://doi.org/10.1007/bf00593171"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/b978-1-4831-9942-9.50008-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013593729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9150(75)90072-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016044205"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/cclm.1975.13.9.407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017592544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/cclm.1975.13.9.407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017592544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-65249-3_11", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021538780", 
          "https://doi.org/10.1007/978-3-642-65249-3_11"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(77)90975-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026390730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(76)90156-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032152782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1552-4604.1975.tb01483.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034174398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci108229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036021986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/cclm.1974.12.9.403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036691854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1515/cclm.1974.12.9.403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036691854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/cs055325s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037983031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/cs055325s", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037983031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/cs047009pa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040558120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/cs047009pa", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040558120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(78)90177-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049451893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01747716", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053519233", 
          "https://doi.org/10.1007/bf01747716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01747716", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053519233", 
          "https://doi.org/10.1007/bf01747716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076279896", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078454423", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1980-07", 
    "datePublishedReg": "1980-07-01", 
    "description": "The fasting level of plasma very low density lipoproteins (VLDL) was increased by 30 to 50% in 12 healthy male volunteers treated with daily oral doses of hydrochlorothiazide 100 mg, chlorthalidone 100 mg or furosemide 80 mg for 3 weeks in a cross-over trial. Hydrochlorothiazide and chlorthalidone, but not furosemide, caused a 10% increase in cholesterol in the low density lipoproteins (LDL), whereas triglycerides and phospholipids in this fraction remained unchanged. High density lipoproteins (HDL) were not affected by any of the diuretics. Free palmitic and oleic acid in plasma were also increased during the treatment, perhaps because of an accumulation of cyclic 3\u20325\u2032-AMP due either to the inhibitory action of diuretics on phosphodiesterase, or to secondary activation of the sympathetic nervous systems. This would activate lipolysis in fat tissue, which in turn may induce VLDL synthesis in the liver. Each of the diuretics caused a similar rise of 20 to 30% in the mean plasma uric acid, the which could not be correlated with either triglycerides or cholesterol. Plasma sodium was increased by 2% only by furosemide, whereas potassium was decreased by 15 and 19% by hydrochlorothiazide and chlorthalidone, respectively, but not by furosemide. Mean plasma creatinine rose by 3.5% on treatment with furosemide, and by 6% with the other two diuretics. Mean body weight was reduced by 1,4 to 2,0% during treatment. No change in fasting blood sugar, plasma protein level or hematocrit was found.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00625798", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Effects of diuretics on plasma lipoproteins in healthy men", 
    "pagination": "251-257", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00625798"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8ed839c147beec875e13af45d5936bda85b451a6b1ed373bb3ab1da9463c13f2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1029985014"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6995127"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00625798", 
      "https://app.dimensions.ai/details/publication/pub.1029985014"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T08:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91432_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00625798"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00625798'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00625798'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00625798'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00625798'


 

This table displays all metadata directly associated to this object as RDF triples.

215 TRIPLES      21 PREDICATES      66 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00625798 schema:about N0d77d340d4a247b69b83e14200039dfc
2 N13ed300a3f9b49359e83219dcdc404fb
3 N299195627b2b4690b163d35690e1cb5b
4 N4b6e2396b51548488abff940b5dacac4
5 N4bec360d9b4a4f5a902163dbb9316d43
6 N569712540de040f3ae0e232458a78fe1
7 N5b3a11a3a3a94ee4b53a4f54834e548f
8 N6316db11fd5e419da63e4e233d65c0ff
9 N77f0335b96bb485a9847ac1d56596baf
10 N7c957107eecd4061a5b5818e7b6da1d0
11 N7ce1eb70731f4b1497cff017d649d84f
12 N7d4ecf2ff304469b9d1806a4faa5552f
13 N8a6aedd4e5d84d958cb3b94d6588dbbc
14 N99f660d852b247f485af153f78a0685d
15 N9e52d3e7280e49d78029f0fff63ae9be
16 Nb2ad1196decc4c46b42d2582b0658062
17 Ncc8d0d705bcb47aaa8940ed193163ad3
18 Neb6c9d51b3d8428fa859b987d74e3a13
19 anzsrc-for:11
20 anzsrc-for:1101
21 schema:author N1cc90067e6f441f3ac6155ccc7439f92
22 schema:citation sg:pub.10.1007/978-3-642-65249-3_11
23 sg:pub.10.1007/bf00593171
24 sg:pub.10.1007/bf01747716
25 https://app.dimensions.ai/details/publication/pub.1076279896
26 https://app.dimensions.ai/details/publication/pub.1078454423
27 https://doi.org/10.1001/jama.1964.03070220062023
28 https://doi.org/10.1002/j.1552-4604.1975.tb01483.x
29 https://doi.org/10.1016/0002-9343(76)90156-x
30 https://doi.org/10.1016/0002-9343(78)90177-8
31 https://doi.org/10.1016/0021-9150(75)90072-6
32 https://doi.org/10.1016/b978-1-4831-9942-9.50008-5
33 https://doi.org/10.1016/s0140-6736(77)90975-8
34 https://doi.org/10.1042/cs047009pa
35 https://doi.org/10.1042/cs055325s
36 https://doi.org/10.1111/j.1749-6632.1960.tb20075.x
37 https://doi.org/10.1172/jci108229
38 https://doi.org/10.1177/000331977602701205
39 https://doi.org/10.1515/cclm.1974.12.9.403
40 https://doi.org/10.1515/cclm.1975.13.9.407
41 schema:datePublished 1980-07
42 schema:datePublishedReg 1980-07-01
43 schema:description The fasting level of plasma very low density lipoproteins (VLDL) was increased by 30 to 50% in 12 healthy male volunteers treated with daily oral doses of hydrochlorothiazide 100 mg, chlorthalidone 100 mg or furosemide 80 mg for 3 weeks in a cross-over trial. Hydrochlorothiazide and chlorthalidone, but not furosemide, caused a 10% increase in cholesterol in the low density lipoproteins (LDL), whereas triglycerides and phospholipids in this fraction remained unchanged. High density lipoproteins (HDL) were not affected by any of the diuretics. Free palmitic and oleic acid in plasma were also increased during the treatment, perhaps because of an accumulation of cyclic 3′5′-AMP due either to the inhibitory action of diuretics on phosphodiesterase, or to secondary activation of the sympathetic nervous systems. This would activate lipolysis in fat tissue, which in turn may induce VLDL synthesis in the liver. Each of the diuretics caused a similar rise of 20 to 30% in the mean plasma uric acid, the which could not be correlated with either triglycerides or cholesterol. Plasma sodium was increased by 2% only by furosemide, whereas potassium was decreased by 15 and 19% by hydrochlorothiazide and chlorthalidone, respectively, but not by furosemide. Mean plasma creatinine rose by 3.5% on treatment with furosemide, and by 6% with the other two diuretics. Mean body weight was reduced by 1,4 to 2,0% during treatment. No change in fasting blood sugar, plasma protein level or hematocrit was found.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree false
47 schema:isPartOf N4ee501da519244d1b6894c54d3168baa
48 Na2f671d2fb2b48879b2e3a9ea0809610
49 sg:journal.1054337
50 schema:name Effects of diuretics on plasma lipoproteins in healthy men
51 schema:pagination 251-257
52 schema:productId N1c6eb630110f4498aac5499297a92f60
53 N5880270fa8264784aa40d43b7bf6e375
54 Na6b0539a0d5f48fcbb8006e7a849bcb4
55 Ndf408b1c02e34ec183baef0324fe41de
56 Nffc78789130143a5afe40194bc585544
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029985014
58 https://doi.org/10.1007/bf00625798
59 schema:sdDatePublished 2019-04-15T08:59
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher Nc8048491359f4bb5b933f015192bd40f
62 schema:url http://link.springer.com/10.1007/BF00625798
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N0d77d340d4a247b69b83e14200039dfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Cholesterol
68 rdf:type schema:DefinedTerm
69 N13ed300a3f9b49359e83219dcdc404fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Lipoproteins, HDL
71 rdf:type schema:DefinedTerm
72 N1c6eb630110f4498aac5499297a92f60 schema:name doi
73 schema:value 10.1007/bf00625798
74 rdf:type schema:PropertyValue
75 N1cc90067e6f441f3ac6155ccc7439f92 rdf:first sg:person.01370452303.55
76 rdf:rest Nc7daa845556c41679df3d7e776ca815b
77 N299195627b2b4690b163d35690e1cb5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Humans
79 rdf:type schema:DefinedTerm
80 N4b6e2396b51548488abff940b5dacac4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Furosemide
82 rdf:type schema:DefinedTerm
83 N4bec360d9b4a4f5a902163dbb9316d43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Placebos
85 rdf:type schema:DefinedTerm
86 N4ee501da519244d1b6894c54d3168baa schema:volumeNumber 17
87 rdf:type schema:PublicationVolume
88 N569712540de040f3ae0e232458a78fe1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Diuretics
90 rdf:type schema:DefinedTerm
91 N5880270fa8264784aa40d43b7bf6e375 schema:name dimensions_id
92 schema:value pub.1029985014
93 rdf:type schema:PropertyValue
94 N590256c82ec34ab3acdb1749299c9e27 schema:affiliation Nd8a565a992d54f9390bb2953e0a0e142
95 schema:familyName Reinhold-Kourniati
96 schema:givenName D.
97 rdf:type schema:Person
98 N5b3a11a3a3a94ee4b53a4f54834e548f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Lipoproteins, VLDL
100 rdf:type schema:DefinedTerm
101 N6316db11fd5e419da63e4e233d65c0ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Administration, Oral
103 rdf:type schema:DefinedTerm
104 N77f0335b96bb485a9847ac1d56596baf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Male
106 rdf:type schema:DefinedTerm
107 N7c957107eecd4061a5b5818e7b6da1d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Fatty Acids, Nonesterified
109 rdf:type schema:DefinedTerm
110 N7ce1eb70731f4b1497cff017d649d84f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Phospholipids
112 rdf:type schema:DefinedTerm
113 N7d4ecf2ff304469b9d1806a4faa5552f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Clinical Trials as Topic
115 rdf:type schema:DefinedTerm
116 N8a6aedd4e5d84d958cb3b94d6588dbbc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Chlorthalidone
118 rdf:type schema:DefinedTerm
119 N99f660d852b247f485af153f78a0685d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Lipoproteins, LDL
121 rdf:type schema:DefinedTerm
122 N9e52d3e7280e49d78029f0fff63ae9be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Hydrochlorothiazide
124 rdf:type schema:DefinedTerm
125 Na2f671d2fb2b48879b2e3a9ea0809610 schema:issueNumber 4
126 rdf:type schema:PublicationIssue
127 Na6b0539a0d5f48fcbb8006e7a849bcb4 schema:name readcube_id
128 schema:value 8ed839c147beec875e13af45d5936bda85b451a6b1ed373bb3ab1da9463c13f2
129 rdf:type schema:PropertyValue
130 Nb2ad1196decc4c46b42d2582b0658062 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Lipoproteins
132 rdf:type schema:DefinedTerm
133 Nc7daa845556c41679df3d7e776ca815b rdf:first sg:person.0577236243.18
134 rdf:rest Nef58357b721c48e6b44721b4cbbf4bea
135 Nc8048491359f4bb5b933f015192bd40f schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 Nc89a874114a84ef5980870c3f360956d schema:name Department of Clinical Pharmacology, Free University of Berlin, Klinikum Steglitz, Berlin, Germany
138 rdf:type schema:Organization
139 Ncc8d0d705bcb47aaa8940ed193163ad3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Sodium Chloride Symporter Inhibitors
141 rdf:type schema:DefinedTerm
142 Nd8a565a992d54f9390bb2953e0a0e142 schema:name Department of Clinical Pharmacology, Free University of Berlin, Klinikum Steglitz, Berlin, Germany
143 rdf:type schema:Organization
144 Ndf408b1c02e34ec183baef0324fe41de schema:name pubmed_id
145 schema:value 6995127
146 rdf:type schema:PropertyValue
147 Ne0bf505dc02249d5a3b037b85125947b schema:name Department of Clinical Pharmacology, Free University of Berlin, Klinikum Steglitz, Berlin, Germany
148 rdf:type schema:Organization
149 Neb6c9d51b3d8428fa859b987d74e3a13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Adult
151 rdf:type schema:DefinedTerm
152 Nef58357b721c48e6b44721b4cbbf4bea rdf:first N590256c82ec34ab3acdb1749299c9e27
153 rdf:rest rdf:nil
154 Nffc78789130143a5afe40194bc585544 schema:name nlm_unique_id
155 schema:value 1256165
156 rdf:type schema:PropertyValue
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1101 schema:inDefinedTermSet anzsrc-for:
161 schema:name Medical Biochemistry and Metabolomics
162 rdf:type schema:DefinedTerm
163 sg:journal.1054337 schema:issn 0031-6970
164 1432-1041
165 schema:name European Journal of Clinical Pharmacology
166 rdf:type schema:Periodical
167 sg:person.01370452303.55 schema:affiliation Nc89a874114a84ef5980870c3f360956d
168 schema:familyName Joos
169 schema:givenName C.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370452303.55
171 rdf:type schema:Person
172 sg:person.0577236243.18 schema:affiliation Ne0bf505dc02249d5a3b037b85125947b
173 schema:familyName Kewitz
174 schema:givenName H.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577236243.18
176 rdf:type schema:Person
177 sg:pub.10.1007/978-3-642-65249-3_11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021538780
178 https://doi.org/10.1007/978-3-642-65249-3_11
179 rdf:type schema:CreativeWork
180 sg:pub.10.1007/bf00593171 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010779101
181 https://doi.org/10.1007/bf00593171
182 rdf:type schema:CreativeWork
183 sg:pub.10.1007/bf01747716 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053519233
184 https://doi.org/10.1007/bf01747716
185 rdf:type schema:CreativeWork
186 https://app.dimensions.ai/details/publication/pub.1076279896 schema:CreativeWork
187 https://app.dimensions.ai/details/publication/pub.1078454423 schema:CreativeWork
188 https://doi.org/10.1001/jama.1964.03070220062023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006015100
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1002/j.1552-4604.1975.tb01483.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034174398
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/0002-9343(76)90156-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032152782
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/0002-9343(78)90177-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049451893
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/0021-9150(75)90072-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016044205
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/b978-1-4831-9942-9.50008-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013593729
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/s0140-6736(77)90975-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026390730
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1042/cs047009pa schema:sameAs https://app.dimensions.ai/details/publication/pub.1040558120
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1042/cs055325s schema:sameAs https://app.dimensions.ai/details/publication/pub.1037983031
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1111/j.1749-6632.1960.tb20075.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006784252
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1172/jci108229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036021986
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1177/000331977602701205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002523464
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1515/cclm.1974.12.9.403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036691854
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1515/cclm.1975.13.9.407 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017592544
215 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...